Ketamine Completed Phase 2 Trials for Pain Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02199678A Study to Assess the Analgesic Properties of a Sublingual Wafer Formulation of Ketamine Following Third Molar Extraction
NCT02356965Study Testing Ketamine Sublingual Wafer After Wisdom Tooth Extraction
NCT02857361Crossover Study to Evaluate the PK Effects of Two Different Wafer Administration Protocols.
NCT01047241Nasal Administration of Sufentanil+Ketamine for Procedure-related Pain in Children